8 Paid Clinical Research Studies in Chula Vista, California

Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence

This research study is being conducted to improve eye care by using artificial intelligence (AI) to make diabetic eye screenings faster and more accessible. AI technology mimics hu

📍 San Ysidro Health Chula Vista — Chula Vista, California

💵 Participants will receive a copy of the results immediately after completion of the screening.

A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)

Researchers are looking for new weight loss medicines for people with higher body weight. The study medicine, MK-4082, is different from similar weight loss medicines because peopl

📍 ProSciento Inc. ( Site 0002) — Chula Vista, California

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque psori

📍 Exalt Clinical Research — Chula Vista, California

💵 Participants in Part A will initially be assigned to receive either zasocitinib or placebo for the first 16 weeks of tre

In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy

Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented

📍 Northgate Gonzalez Market — Chula Vista, California

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study designed to evaluate the efficacy and safety of praliciguat in adults with biopsy-confirmed focal

📍 Investigator Site #2 — Chula Vista, California

💵 Following this double-blind period, all participants will receive praliciguat in an open-label extension for an addition

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese

📍 ProSciento, INC — Chula Vista, California

Collection of Samples USOPTIVAL Study

A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfD

📍 Precision Recearch Institute — Chula Vista, California

A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects

A Single Center, Single Dose, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

📍 ProSciento, Inc. — Chula Vista, California